Bonmax PTH 750mcg Injection

Composition Teriparatide (750mcg)
Rx Prescription Required
Pack vial of 3 ml Injection
Storage Store in a refrigerator (2 – 8°C). Do not freeze.
Chemical Class Parathyroid Hormone Analogs
Action Class Parathyroid Hormone (PTH) Analogues
Habbit Forming
Manufacturer Zydus Cadila
Manufacturer address Zydus Tower, Satellite Cross Roads,Ahmedabad â?? 380015 Gujarat, India.

Bonmax PTH 750mcg Injection is a man-made version of the parathyroid hormone used to treat men and postmenopausal women who have severe osteoporosis with a high risk of fractures. It works by stimulating new bone formation, which improves bone density and decreases the risk of spinal fractures.

Bonmax PTH 750mcg Injection should be injected under the skin or given by a healthcare professional. You should use it regularly and at the same time each day to get the maximum benefit from it. Usually, it is recommended to take it for a maximum period of 2 years. However, follow the doctor’s advice and complete the course even if you feel better.

Some common side effects of this medicine include joint pain, injection site reactions (such as pain, swelling, and redness), and nausea. Consult with your doctor if any of these bother you or do not go away.

Before taking this medicine, let your doctor know if you have kidney stones or any other kidney problems, as it can cause an increase in the amount of calcium in blood or urine. Pregnant and breastfeeding mothers should also consult with their doctors before taking this medicine. Your doctor may advise a bone scan to monitor the progress of your treatment.

Osteoporosis

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Bonmax PTH 750mcg Injection is a synthetic form of a natural human hormone called parathyroid hormone (PTH). It works by increasing the number and activity of bone-forming cells (osteoblasts). This strengthens the bones and minimizes the risk of fractures.

Q: What if you forget to take Bonmax PTH Injection?
A: If you miss a dose of Bonmax PTH 750mcg Injection, consult your doctor.

Bonmax PTH 750mcg Injection should be injected every day under the skin (subcutaneous injection) of the thigh or abdomen.

You may have low blood pressure and dizziness during the initial few days.

If you feel dizzy (light-headed) after the injection, sit or lie down until you feel better.

Tell your doctor immediately if you experience nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs of high calcium levels in your blood.

Tell your doctor if you are pregnant, breastfeeding, or planning to become pregnant.

Q. Is Bonmax PTH 750mcg Injection a steroid?

No, Bonmax PTH 750mcg Injection is not a steroid. However, this medicine may be used to treat osteoporosis caused by long-term use of steroids. Generally, this medicine is used to treat osteoporosis in women of the postmenopausal age group and in men who have an increased risk of fracture.

Q. Can I take this medication in long term for osteoporosis?

Bonmax PTH 750mcg Injection should not be taken for a course longer than 2 years. However, your doctor may prescribe Bonmax PTH 750mcg Injection for more than 2 years if you remain at or have returned to having a high risk for fracture.

Q. How is Bonmax PTH 750mcg Injection stored at home?

Always keep this medicine stored in a refrigerator at a temperature of about 2°C to 8°C. Be cautious; the temperature should not decrease further, as freezing may cause the medicine to get damaged and can lead to loss of activity. Therefore, avoid placing the Bonmax PTH 750mcg Injection pens close to the ice compartment of the refrigerator. If properly stored, this medication can be used up to 28 days after the first injection. If the pen is not empty within 28 days, please discard it safely.

Q. Who should not use Bonmax PTH 750mcg Injection?

The doctor will decide whether the medicine is required for a patient or not. There are a few conditions in which the use of Bonmax PTH 750mcg Injection should be avoided, such as in patients with kidney impairment, Paget’s disease, any type of bone cancer, or unexplained high levels of serum calcium. It should also be avoided by children, young adults (who are still in the growing age), and pregnant or lactating females. Hence, before starting the medication, inform the doctor about any medical conditions and the medication you are taking. This will help the doctor design a proper therapy for you.

Joint pain

Injection site reactions (pain, swelling, redness)

Nausea

Alcohol:CAUTION

Caution is advised when consuming alcohol with Bonmax PTH 750mcg Injection. Please consult your doctor.

Pregnancy:CONSULT YOUR DOCTOR

Bonmax PTH 750mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding:CONSULT YOUR DOCTOR

Information regarding the use of Bonmax PTH 750mcg Injection during breastfeeding is not available. Please consult your doctor.

Driving:UNSAFE

Bonmax PTH 750mcg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney:CAUTION

Bonmax PTH 750mcg Injection should be used with caution in patients with kidney disease. Dose adjustment of Bonmax PTH 750mcg Injection may be needed. Please consult your doctor.Use of Bonmax PTH 750mcg Injection is not recommended in patients with severe kidney disease.

Liver:CONSULT YOUR DOCTOR

There is limited information available on the use of Bonmax PTH 750mcg Injection in patients with liver disease. Please consult your doctor.

Bikle DD. Agents That Affects Bone Mineral Homoestasis. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 766.
Friedman PA. Agents Affecting Mineral Ion Homeostasis and Bone Turnover. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1300
Teriparatide. Indianapolis, Indiana: Lilly France; 2008. [Accessed 02 Apr. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from: View
Teriparatide injection [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC; 2024. [Accessed 01 Apr. 2025] (online) Available from: View